A health outcome assessment of the Cardio Metabolic Mission Health Program at Novartis.

Objective: To assess the impact of the Novartis Cardio Metabolic Program--an education, awareness, and health management initiative--on hypertension, hyperlipidemia, diabetes mellitus, and obesity within the Novartis employee population.

Methods: A prospective, 6-month pre-/post assessment to determine improvement in blood pressure (BP) control and risk factors after implementation of Novartis Cardio Metabolic.

Results: A total of 238 subjects with cardiovascular risk factors participated.